These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet. Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407 [TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain. Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693 [TBL] [Abstract][Full Text] [Related]
26. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A; Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236 [TBL] [Abstract][Full Text] [Related]
27. A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples. Swank Z; Michielin G; Yip HM; Cohen P; Andrey DO; Vuilleumier N; Kaiser L; Eckerle I; Meyer B; Maerkl SJ Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33945500 [TBL] [Abstract][Full Text] [Related]
28. Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection. Miesse PK; Collier BB; Grant RP Sci Rep; 2022 Apr; 12(1):5812. PubMed ID: 35388074 [TBL] [Abstract][Full Text] [Related]
29. Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2. Iankov I; Viker K; Turgeon C; Matern D; Galanis E J Immunol Methods; 2021 May; 492():112996. PubMed ID: 33582147 [TBL] [Abstract][Full Text] [Related]
30. A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccination. Du J; Zhang D; Pathakamuri JA; Kuebler D; Yang Y; Loginova Y; Chu E; Madej R; Neves JV; Singer B; Radke H; Spencer N; Rizk E; Zhang A; Lu CM; Sha MY Emerg Microbes Infect; 2022 Dec; 11(1):250-259. PubMed ID: 34951566 [TBL] [Abstract][Full Text] [Related]
31. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies. Schallier A; De Baets S; De Bruyne D; Dauwe K; Herpol M; Couck P Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115403. PubMed ID: 34058541 [TBL] [Abstract][Full Text] [Related]
32. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response. Nikiforuk AM; McMillan B; Bartlett SR; Márquez AC; Pidduck T; Kustra J; Goldfarb DM; Barakauskas V; Sinclair G; Patrick DM; Sadarangani M; Ogilvie GS; Krajden M; Morshed M; Sekirov I; Jassem AN Microbiol Spectr; 2022 Apr; 10(2):e0140521. PubMed ID: 35266818 [TBL] [Abstract][Full Text] [Related]
33. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2. Roxhed N; Bendes A; Dale M; Mattsson C; Hanke L; Dodig-Crnković T; Christian M; Meineke B; Elsässer S; Andréll J; Havervall S; Thålin C; Eklund C; Dillner J; Beck O; Thomas CE; McInerney G; Hong MG; Murrell B; Fredolini C; Schwenk JM Nat Commun; 2021 Jun; 12(1):3695. PubMed ID: 34140485 [TBL] [Abstract][Full Text] [Related]
35. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection. Manisty C; Treibel TA; Jensen M; Semper A; Joy G; Gupta RK; Cutino-Moguel T; Andiapen M; Jones J; Taylor S; Otter A; Pade C; Gibbons J; Lee J; Bacon J; Thomas S; Moon C; Jones M; Williams D; Lambourne J; Fontana M; Altmann DM; Boyton R; Maini M; McKnight A; Chain B; Noursadeghi M; Moon JC EBioMedicine; 2021 Mar; 65():103259. PubMed ID: 33662833 [TBL] [Abstract][Full Text] [Related]
36. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays. Zava TT; Zava DT Bioanalysis; 2021 Jan; 13(1):13-28. PubMed ID: 33319585 [No Abstract] [Full Text] [Related]
37. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
38. Self-sampling of capillary blood for SARS-CoV-2 serology. Brown L; Byrne RL; Fraser A; Owen SI; Cubas-Atienzar AI; Williams CT; Kay GA; Cuevas LE; Fitchett JRA; Fletcher T; Garrod G; Kontogianni K; Krishna S; Menzies S; Planche T; Sainter C; Staines HM; Turtle L; Adams ER Sci Rep; 2021 Apr; 11(1):7754. PubMed ID: 33833246 [TBL] [Abstract][Full Text] [Related]
39. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica. Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776 [TBL] [Abstract][Full Text] [Related]
40. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. National SARS-CoV-2 Serology Assay Evaluation Group Lancet Infect Dis; 2020 Dec; 20(12):1390-1400. PubMed ID: 32979318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]